Skip to main content
NCBI home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;94(3):240–243. doi: 10.1111/j.1349-7006.2003.tb01427.x

Thymic lymphomas in Wistar rats exposed to N‐methyl‐N‐nitrosourea (MNU)

Carla Adriene da Silva Franchi 1, Maura Moscardi Bacchi 2, Carlos Roberto Padovani 3, João Lauro Viana de Camargo 1,2,4
PMCID: PMC11160241  PMID: 12824916

Abstract

The Brazilian Agency for the Environment (IBAMA) recently adopted an alternative medium‐term multiple‐organ assay system with the Wistar rat strain for detection of the carcinogenic potential of pesticides. Originally, this initiation‐promotion protocol was established in Japan with the isogenic Fischer 344 male rat. Among the initiating agents used in that assay, N‐methyl‐N‐nitrosourea (MNU) rapidly induces malignant lymphoma and leukemia and early mortality of rats from different strains. This study was developed to evaluate whether the outbred Wistar rats are also similarly susceptible to MNU. Particularly, it aimed to evaluate the dose‐response relationship and to register the MNU‐induced pre‐neoplasia and neoplasia that may develop in the lympho‐hematopoietic system (LHS) of the Wistar rat within a medium‐term period. Four groups of male Wistar rats were treated during 2 weeks with vehicle or with MNU (80, 160 or 240 mg/kg body weight, i.p.). After sacrifice at the 12th and 20th weeks, the thymus, spleen, bone marrow, cervical and mesenteric lymph nodes and liver were collected for analysis. At the 20th week, LHS malignant tumors and benign vascular tumors occurred only in the high‐ and intermediate‐dose MNU‐treated animals. Four animals treated with 240 mg/kg developed diffuse thymic lymphomas; two others, treated respectively with 240 mg/kg and 160 mg/kg, developed spleen hemangiomas. The present observations indicate that the Wistar strain is as susceptible as other strains to the early development of MNU‐induced LHS (pre)neoplasia. Therefore, this strain seems suitable to be used as test system in bioassay protocols that adopt MNU as an initiating agent for carcinogenesis. (Cancer Sci 2003; 94: 240–243)

References

  • 1. Bannasch P, Griesemer RA. Long‐term assays for carcinogenicity in animals. In: Montesano R, Bartsch H, Vainio H, Wilbourn J, Yamasaki H, editors. Long‐term and short‐term assays for carcinogens: a critical appraisal. IARC Sci Publ; 1986; 83: 13–83. [PubMed] [Google Scholar]
  • 2. Chhabra RS, Huff JE, Schwetz BS, Selkirk J. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ Health Perspect 1990; 86: 313–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Boorman GA, Maronpot RR, Eustis SL. Rodent carcinogenesis bioassay: past, present and future. Toxicol Pathol 1994; 22: 105–11. [DOI] [PubMed] [Google Scholar]
  • 4. Ito N, Imaida K, Tsuda H, Shibata M, Aoki T, de Camargo JLV, Fukushima S. Wide‐spectrum initiation models: possible applications to medium‐term multiple organ bioassays for carcinogenesis modifiers. Jpn J Cancer Res 1988; 79: 413–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Shirai T, Hirose M, Ito N. Medium‐term bioassays in rats for rapid detection of the carcinogenic potential of chemicals. In: McGregor DB, Rice JM, Venitt S, editors. The use of short‐ and medium‐term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. IARC Sci Publ; 1999; 146: 251–72. [PubMed] [Google Scholar]
  • 6. Hagiwara A, Tanaka H, Imaida K, Tamano S, Fukushima S, Ito N. Correlation between medium‐term multi‐organ carcinogenesis bioassay data and long‐term observation results in rats. Jpn J Cancer Res 1993; 84: 237–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Brazilian Institute of Environmental and Renewable Natural Resources (IBAMA) .Normative Act No.84, (October 15 1996) (in Portuguese).
  • 8. Spinardi ALT, Kaneno R, Rodrigues MAM, Salvadori DMF, Rocha NS, Barbisan LF, Ribeiro LR, de Camargo JLV. Natural killer activity in a medium‐term multi‐organ bioassay for carcinogenesis. Jpn J Cancer Res 1999; 90: 101–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Moreira ELT, de Camargo JLV, Rodrigues MAM., Barbisan LF, Salvador! DMF. Dose‐ and sex‐related carcinogenesis by N‐bis(2‐hydroxypropyl)nitro‐samine in Wistar rats. Jpn J Cancer Res 2000; 91: 368–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Uwagawa S, Tsuda H, Inoue T, Tagawa Y, Aoki T, Kagawa M, Ogiso T, Ito N. Enhancing potencial of 6 different carcinogens on multi‐organ tumorigen‐esis after initial treatment with N‐methyl‐N‐nitrosourea. Jpn J Cancer Res 1991; 82: 1397–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Tsuda H, Fukushima S, Imaida K, Kurata Y, Ito N. Organ specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver and urinary bladder tumors in rats after initiation with N‐nitrosomethylurea. Cancer Res 1983; 43: 3292–6. [PubMed] [Google Scholar]
  • 12. Mizoguchi M, Naito H, Kurata Y, Shibata M‐A, Tsuda H, Wild CP, Montesano R, Fukushima S. Influence of aging on multi‐organ carcinogenesis in rats induced by N‐methyl‐N‐nitrosourea. Jpn J Cancer Res 1993; 84: 139–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Kociba RJ, Kociba GJ. Assessment of toxicologic effects upon bone marrow and related tissues. In: Jones TC, Ward JM, Mohr U, Hunt RD, editors. Monographs on the pathology of laboratory animals (hemopoietic system). Berlin‐Heidelberg : Springer‐Verlag; 1990. p. 79–87. [Google Scholar]
  • 14. Ito N, Shirai T, Hasegawa R. Medium‐term bioassays for carcinogens. In: Vainio H, Magee PN, McGregor DB, McMichael AJ, editors . Mechanisms of carcinogenesis in risk identification. Lyon : International Agency for Research on Cancer (IARC); 1992. p. 353–88. [Google Scholar]
  • 15. Hsu SM, Raine L, Fanger N. Use of avidin‐biotin‐peroxidase complex (ABC) and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80. [DOI] [PubMed] [Google Scholar]
  • 16. Luna LG. Histopathologic methods and color atlas of special stains and tissues artifacts. Washington : American Histolabs; 1992. p. 275–6. [Google Scholar]
  • 17. Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics 1965; 7: 247–54. [Google Scholar]
  • 18. Ogiu T. T‐Cell lymphoma, thymic origin, rat. In: Jones TC, Ward JM, Mohr U, Hunt RD, editors. Monographs on pathology of laboratory animals (Hemopoietic System). Berlin‐Heidelberg : Springer‐Verlag; 1990. p. 286–92. [Google Scholar]
  • 19. Harkness JE, Wagner JE. The biology and medicine of rabbits and rodents. Media : Williams ' Wilkins; 1995. p. 95. [Google Scholar]
  • 20. Hayashi S, Nonoyama T, Miyajima H. Spontaneous non‐thymic cell lympho‐mas in young Wistar rats. Vet Pathol 1989; 26: 326–32. [DOI] [PubMed] [Google Scholar]
  • 21. Koestner AW, Ruecker FA, Koestner A. Morphology and pathogenesis of tumors of the thymus and stomach in Sprague‐Dawley rats following intragas‐tric administration of methylnitrosourea (MNU). Int J Cancer 1977; 20: 418–26. [DOI] [PubMed] [Google Scholar]
  • 22. Shisa H, Hiai H. Genetically determined susceptibility of Fischer 344 rats to propylnitrosourea‐induced thymic lymphomas. Cancer Res 1985; 45: 1483–7. [PubMed] [Google Scholar]
  • 23. Dumenco LL, Allay E, Norton K, Gerson SL. The prevention of thymic lymphomas in transgenic mice by human O'‐alkylguanine‐DNA alkyltrans‐ferase. Science 1993; 59: 219–22. [DOI] [PubMed] [Google Scholar]
  • 24. Gerson SL, Miller K, Berger NA. O6 alkylguanine‐DNA alkyltransferase activity in human myeloid cells. J Clin Invest 1985; 76: 2106–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Fong LY, Jensen DE, Magee PN. DNA methyl‐adduct dosimetry and O6‐alkylguanine‐DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N‐methylnitrosourea. Carcinogenesis 1990; 11: 411–7. [DOI] [PubMed] [Google Scholar]
  • 26. Swenberg JA, Koestner A, Wechsler W, Brunden MN, Abe H. Differential oncogenic effects of methylnitrosourea. J Natl Cancer Inst 1975; 54: 86–95. [DOI] [PubMed] [Google Scholar]
  • 27. Moore MA, Tsuda H, Tamano S, Hagiwara A, Imaida K, Shirai T, Ito, N. Marriage of a medium‐term liver model to surrogate markers–a practical approach for risk and benefit assessment. Toxicol Pathol 1999; 27: 237–42. [DOI] [PubMed] [Google Scholar]
  • 28. Yoshida Y, Tatematsu M, Takaba K, Iwasaki S, Ito, N. Target organ specificity of cell proliferation induced by various carcinogens. Toxicol Pathol 1993; 21: 436–42. [DOI] [PubMed] [Google Scholar]
  • 29. Losco P. Normal development, growth and aging of the spleen. In: Mohr U, Dungworth DL, Capen CC, editors. Pathobiology of the aging rat. Washington : International Life Sciences Institute; 1992. p. 75–93. [Google Scholar]
  • 30. Ward JM. Classification of reactive lesions, spleen. In: Jones TC, Ward JM, Mohr U, Hunt RD, editors. Monographs on pathology of laboratory animals (Hemopoietic System). Berlin‐Heidelberg : Springer‐Verlag; 1990. p. 220–6. [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES